Insiders · Profile

Ali Faraz

Chief Executive Officer at Tenaya Therapeutics. Filing since 16 Aug 2023. CIK 0001667937

Company
Date
Role
Action
Shares
Amount
Of holding
17 Aug 2026
Chief Executive Officer
Sold at will
22,232
$15.78K
5.1%
18 May 2026
Chief Executive Officer
Sold at will
3,390
$2.69K
0.8%
17 Feb 2026
Chief Executive Officer
Sold at will
14,862
$9.56K
3.2%
17 Nov 2025
Chief Executive Officer
Sold at will
3,126
$4.16K
1.0%
18 Aug 2025
Chief Executive Officer
Sold at will
14,533
$18.21K
4.6%
16 May 2025
Chief Executive Officer
Sold at will
3,189
$1.41K
1.0%
10 Mar 2025
Chief Executive Officer
Sold at will
9,741
$5.24K
2.9%
16 Aug 2024
Chief Executive Officer
Sold at will
9,748
$28.22K
4.9%
16 Feb 2024
Chief Executive Officer
Sold at will
6,358
$37.26K
5.3%
16 Aug 2023
Chief Executive Officer
Sold at will
5,563
$21.20K
4.5%
10 decisions on file.